Lynwood Capital Management Inc. X4 Pharmaceuticals, Inc Transaction History

Lynwood Capital Management Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.82 - $2.49 $307,500 - $933,750	-375,000 Reduced 41.67%	525,000 $1.02 Million
Q1 2023 May 12, 2023	SELL	$0.8 - $1.22 $1 Million - $1.53 Million	-1,255,100 Reduced 58.24%	900,000 $783,000
Q4 2022 Feb 07, 2023	BUY	$0.69 - $2.21 $1.49 Million - $4.76 Million	2,155,100 New	2,155,100 $2.14 Million

103

99.9M

213K

50.6K

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $54.9M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

Get notified when there are updates to the investment portfolio of Lynwood Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Lynwood Capital Management Inc. with notifications on news.